Brazil tears up Abbott deal, threatens to violate Kaletra patent

Brazil is again threatening to break Abbott's patent on Kaletra if it won't offer the country a deeper discount on the AIDS drug. Several Brazilian labs have reported to the government that they can manufacture and sell Kaletra for 41 cents per pill, far less than the $1.17 per pill that Abbott charges. A spokesperson for Abbott said the company had thought that it had already struck a fair deal to discount Kaletra, an antiretroviral, but that the company would continue to negotiate in good faith.

- read this article in The New York Times for more